Molecular Mechanisms of Retinal cGMP-Activated Ion Channels
Molecular Mechanisms of Retinal cGMP-Activated Ion Channels
批准号:
8204534
负责人:
MICHAEL D. VARNUM
金额:
$35.07万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-04 至 2013-11-30
关键词:
AddressApoptosisAreaBindingBiochemicalBlindnessBrainCalciumCalmodulinCell DeathCell SurvivalCellsCessation of lifeCodeCon-ferCyclic GMPDataDefectDevelopmentDiseaseEventFunctional disorderGenesGoalsHealthHomeostasisHumanIn VitroIon ChannelIon Channel ProteinKnowledgeLeadLinkMacular degenerationMolecularMutationOutcomePhosphatidylinositolsPhotoreceptorsPhototransductionPredispositionPrevention approachProcessProductionProgress ReportsProteinsPublic HealthPublishingRegulationRegulatory PathwayResearchResearch DesignResearch MethodologyResourcesRetinalRetinal ConeRetinal DegenerationRetinal DiseasesRetinitis PigmentosaRoleSignal TransductionTestingTransgenesTransgenic OrganismsVisionVision DisordersWorkXenopus oocyteZebrafishachromatopsiabasecyclic-nucleotide gated ion channelsdisease-causing mutationendoplasmic reticulum stressgain of function mutationin vivoinnovationinsightmutantphotoreceptor degenerationpreventretinal rodssuccesstraffickingvisual information
中文摘要
项目摘要/摘要
关于编码环核苷酸的基因突变是如何发生的,在知识上存在一个根本性的缺口。
门控(CNG)离子通道可导致人黄斑变性、视锥细胞营养不良和黄斑变性。
曼斯。我们的长期目标是了解控制这些渠道活动的机制
以及与CNG通道突变相关的视网膜疾病的病理生理学。的核心目标
这一应用是为了确定锥体CNG通道效应的细胞机制
门控或运输突变对细胞活性的影响,以及对控制通道至关重要的结构特征
磷脂酰肌醇。最近,我们已经在功能上表征了几个与疾病相关的突变
CNG锥体通道的CNGA3和CNGB3亚基,并发现对通道门有显著影响。
ING、管制和/或贩运,但这些缺陷的细胞后果尚未确定。
中心假设是锥体CNG通道的功能获得突变导致光感受器死亡
通过增强或不受控制的通道活性,细胞内钙稳态的紊乱和
随后的钙依赖性细胞凋亡。相反,运输缺陷预计会损害细胞的生存能力。
通过内质网(ER)胁迫。拟议研究的理由是,开发一种不充分的-
与CNG通道活动异常相关的光感受器功能障碍和丢失的标准将提供
洞察几种相关视锥细胞营养不良的可能治疗方法。在强劲的初步数据指引下,我们
将通过追求两个具体目标来解决这些问题:(1)确定疾病之间的联系-
视锥CNG通道的相关功能改变及其导致光感受器功能障碍的细胞机制
功能和死亡;以及(2)确定CNGB3能力的机制和相互作用
亚基赋予磷脂酰肌醇对通道控制的敏感性。这些研究将利用分子
以及人CNG的细胞操作、生化方法和/或电生理研究
通道在锥光感受器来源的661W细胞或非洲爪哇卵母细胞中表达,并作为转基因在
斑马鱼视锥感光器。拟议的研究是创新的,因为信息丰富的体外研究将
可推广到体内突变CNG通道的转基因表达。总体而言,拟议的工作是有意义的-
ICANT是因为它有望增强我们对导致视网膜退化的机制的理解-
为预防光感受器丢失的潜在方法提供洞察力。
英文摘要
PROJECT SUMMARY/ABSTRACT
There is a fundamental gap in knowledge regarding how mutations in the genes encoding cyclic nucleotide-
gated (CNG) ion channels can produce achromatopsia, cone dystrophy and macular degeneration in hu-
mans. Our long-term objective is to understand the mechanisms controlling the activity of these channels
and the pathophysiology of retinal diseases associated with CNG channel mutations. The core objectives of
this application are to determine the cellular mechanisms responsible for the effect of cone CNG channel
gating or trafficking mutations on cell viability, and the structural features critical for control of channels by
phosphoinositides. Recently, we have functionally characterized several disease-associated mutations in
the CNGA3 and CNGB3 subunits of cone CNG channels and discovered dramatic effects on channel gat-
ing, regulation and/or trafficking, but the cellular consequences of these defects have not been determined.
The central hypothesis is that gain-of-function mutations in cone CNG channels lead to photoreceptor death
via enhanced or uncontrolled channel activity, disturbance of intracellular calcium (Ca2+) homeostasis and
subsequent Ca2+-dependent apoptosis. Conversely, trafficking defects are expected to impair cell viability
via endoplasmic reticulum (ER) stress. The rationale for the proposed research is that developing an under-
standing of photoreceptor dysfunction and loss associated with abnormal CNG channel activity will provide
insight into possible treatments for several related cone dystrophies. Guided by strong preliminary data, we
will address these issues by pursuing two specific aims: (1) identify the connection between disease asso-
ciated functional changes in cone CNG channels and the cellular mechanisms leading to photoreceptor dys-
function and death; and (2) determine the mechanisms and interactions underlying the ability of CNGB3
subunits to confer sensitivity to channel control by phosphoinositides. These studies will utilize molecular
and cellular manipulations, biochemical approaches and/or electrophysiological studies of human CNG
channels expressed in cone photoreceptor derived 661W cells or Xenopus oocytes, and as transgenes in
zebrafish cone photoreceptors. The proposed research is innovative in that informative in vitro studies will
be extended to transgenic expression of mutant CNG channels in vivo. Overall, the proposed work is signif-
icant because it is expected to enhance our understanding of the mechanisms that lead to retinal degenera-
tion and blindness, and to provide insight into potential approaches for prevention of photoreceptor loss.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Disease-associated mutations in CNGB3 produce gain of function alterations in cone cyclic nucleotide-gated channels.
CNGB3 中与疾病相关的突变会导致锥环核苷酸门控通道的功能改变。
DOI:
--
发表时间:
2005
期刊:
Molecular vision [electronic resource].
影响因子:
--
作者:
[Bright,ScottR, Brown,TravisE, Varnum,MichaelD]
通讯作者:
Varnum,MichaelD
DOI:
10.1085/jgp.201210944
发表时间:
2013-04
期刊:
The Journal of general physiology
影响因子:
--
作者:
[Dai G, Peng C, Liu C, Varnum MD]
通讯作者:
Varnum MD
DOI:
10.1042/bj20111004
发表时间:
2012-01-15
期刊:
The Biochemical journal
影响因子:
--
作者:
[Duricka DL, Brown RL, Varnum MD]
通讯作者:
Varnum MD
DOI:
10.1167/iovs.05-1063
发表时间:
2006-03
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[W. O'brien;C. Krema;T. Heimann;Hongtao Zhao]
通讯作者:
W. O'brien;C. Krema;T. Heimann;Hongtao Zhao
DOI:
10.1021/bi400824x
发表时间:
2013-11-19
期刊:
Biochemistry
影响因子:
2.9
作者:
[Meighan SE, Meighan PC, Rich ED, Brown RL, Varnum MD]
通讯作者:
Varnum MD
共 9 条
Ubiquitin-system manipulations to probe and mitigate ethanol damage in neurons
-
批准号:10357893
-
项目类别:
-
资助金额:$21.69万
-
财政年份:2021
-
负责人:MICHAEL D. VARNUM
-
依托单位:
Molecular Mechanisms of Retinal cGMP-Activated Ion Channels
-
批准号:7994761
-
项目类别:
-
资助金额:$35.09万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
MOLECULAR MECHANISMS OF RETINAL CGMP ACTIVATED CHANNELS
-
批准号:6498349
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
MOLECULAR MECHANISMS OF RETINAL CGMP ACTIVATED CHANNELS
-
批准号:6350901
-
项目类别:
-
资助金额:$22.45万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
Molecular Mechanisms of Retinal cGMP-Activated Channels
-
批准号:6893996
-
项目类别:
-
资助金额:$25.37万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
Molecular Mechanisms of Retinal cGMP-Activated Channels
-
批准号:7230914
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
Molecular Mechanisms of Retinal cGMP-Activated Channels
-
批准号:6780304
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
Molecular Mechanisms of Retinal cGMP-Activated Channels
-
批准号:7057333
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
MOLECULAR MECHANISMS OF RETINAL CGMP ACTIVATED CHANNELS
-
批准号:6038610
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
MOLECULAR MECHANISMS OF RETINAL CGMP ACTIVATED CHANNELS
-
批准号:6628662
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
Molecular Mechanisms of Retinal cGMP-Activated Ion Channels
-
批准号:7582979
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2000
-
负责人:MICHAEL D. VARNUM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: